Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
CURE Pharmaceutical received early financing of $19.0M on 2019-05-29.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $19M | 05/2019 |
| Convertible Note | $10M | 11/2020 |
Zippia gives an in-depth look into the details of CURE Pharmaceutical, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CURE Pharmaceutical. The employee data is based on information from people who have self-reported their past or current employments at CURE Pharmaceutical. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by CURE Pharmaceutical. The data presented on this page does not represent the view of CURE Pharmaceutical and its employees or that of Zippia.
CURE Pharmaceutical may also be known as or be related to CURE Pharmaceutical, CURE Pharmaceutical Holding Corp., Cure Pharmaceutical, Cure Pharmaceutical Corporation and Cure Pharmaceutical Holding Corp.